STOK

Stoke Therapeutics Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 0/10
  • Value↓ 0/10
Stoke Therapeutics sales and earnings growth
STOK Growth
Low
  • Revenue Y/Y↓ -84.64%
  • EPS Y/Y↓ -434.12%
  • FCF Y/Y↓ -313.44%
Stoke Therapeutics gross and profit margin trends
STOK Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -529.20%
  • ROIC 5Y↓ -197.81%
Stoke Therapeutics net debt vs free cash flow
STOK Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -13.0

Stoke Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks